Figure 1.
Outcome of patients with LBCL-IRF4+. (A-B) EFS and OS of the 65 patients with LBCL-IRF4+; (C-D) EFS and OS of the 50 head-and-neck patients with LBCL-IRF4+; (E-F) EFS and OS of the 10 abdominal patients with LBCL-IRF4+.
Outcome of patients with LBCL-IRF4+. (A-B) EFS and OS of the 65 patients with LBCL-IRF4+; (C-D) EFS and OS of the 50 head-and-neck patients with LBCL-IRF4+; (E-F) EFS and OS of the 10 abdominal patients with LBCL-IRF4+.
